Connect with us

Hi, what are you looking for?

AI Research

Sapio Sciences Reveals 62% of Scientists Find ELNs Inefficient, Sparking Shadow AI Use

Sapio Sciences reveals 62% of scientists find electronic lab notebooks inefficient, driving 45% to use unauthorized AI tools for data analysis.

Sapio Sciences, a lab informatics platform focusing on “science-aware” AI, has unveiled research indicating significant dissatisfaction among scientists regarding electronic lab notebooks (ELNs) and AI tools in contemporary laboratory settings. The study, which surveyed 150 scientists from U.S. and European labs across various sectors including biopharma R&D and clinical diagnostics, highlights a troubling trend of frustration with existing lab software that leads to repeated experiments, inefficient data utilization, and an increasing dependence on unauthorized shadow AI.

Despite considerable investments in digital lab technology, the findings reveal that only 62% of scientists feel their ELNs support efficient workflow, while a mere 5% can analyze experimental results without requiring specialist assistance. The lack of effective tools has resulted in nearly two-thirds (65%) of scientists having to repeat experiments due to difficulties in locating or reusing prior results, contributing to unnecessary costs and delays across laboratory teams.

The survey underscores that traditional ELNs are ill-equipped to meet the evolving demands of modern scientific research. A mere 7% of respondents felt their ELN could adapt to new experimental workflows without specialized help, while 56% cited usability issues that complicate their work. Additionally, 51% reported spending excessive time on data import and export tasks, escalating to 81% among scientists based in the U.S. and 72% within pharmaceutical manufacturing contexts. Configuration challenges further exacerbate the situation, with 71% of scientists deeming ELNs difficult to configure or adjust, particularly in pharmaceutical manufacturing, where frustration levels hit 84%.

Mike Hampton, chief commercial officer at Sapio Sciences, commented, “The survey clearly shows a growing mismatch between modern scientific practice and the capabilities of traditional ELNs. Most ELNs were designed as tools that focused on documenting experiments, not actively supporting scientists or guiding next steps.” He emphasized that when scientists are unable to analyze data or build on past experiments without additional assistance, the resultant frustration incurs real costs, wasting resources and hindering scientific discovery.

The limitations of current ELNs have prompted a shift in laboratory behavior, with 45% of scientists reporting their use of public generative AI tools via personal accounts to assist their work. This trend, while offering immediate solutions, raises concerns about security, intellectual property, and compliance risks associated with shadow AI. Sean Blake, Chief Information Officer at Sapio Sciences, noted, “Scientists aren’t turning to public AI because they want to bypass governance. They’re doing it because existing lab tools can’t help them analyze results or determine next steps efficiently.”

As scientists look ahead, they are not seeking merely a means of documenting experiments; instead, they desire interactive, AI-enhanced tools that offer guidance and interpretation. A striking 95% of respondents expressed a preference for conversational, text-based interfaces, and 78% wanted voice interaction. Furthermore, 96% asserted that future ELNs should assist in data interpretation rather than simply capturing it.

Demand for field-specific AI capabilities reflects the specialized needs of different disciplines; for instance, 83% of diagnostics labs and 74% of biopharma R&D professionals prioritize functionalities like retrosynthesis and toxicity prediction. Molecular binding simulations are critical for 71% of biopharma R&D scientists, while genetic sequence optimization is important for 65% of contract research organizations (CROs) and 63% of diagnostics labs.

Rob Brown, head of the scientific office at Sapio Sciences, remarked, “Our research clearly shows that second-generation ELNs have reached the limits of what scientists expect from them.” He added that as they develop the next generation of lab software, the focus will be on AI-enabled analysis and design methods that keep scientists in control while actively supporting their workflows and decision-making processes.

The research findings signal a pivotal moment for lab informatics, suggesting that scientists are not aiming to relinquish control but rather seek AI tools that meaningfully contribute to reasoning and interpretation within regulated laboratory environments. As the landscape of scientific research continues to evolve, the demand for more intuitive and supportive technologies will likely reshape the future of laboratory workflows.

See also
Staff
Written By

The AiPressa Staff team brings you comprehensive coverage of the artificial intelligence industry, including breaking news, research developments, business trends, and policy updates. Our mission is to keep you informed about the rapidly evolving world of AI technology.

You May Also Like

AI Marketing

Omnisend reports that 80% of U.S. shoppers now trust AI for purchases, with 88% willing to share personal data for better product recommendations.

AI Regulation

Southeast Asian legal-tech startups face heightened hurdles entering the U.S. market as Gartner forecasts a 35% rise in AI platform lock-in by 2027.

AI Regulation

Nvidia gains US and China approval to boost AI chip sales, targeting $10 billion in revenue as manufacturing resumes amid high market demand.

AI Government

U.S. Defense Secretary Pete Hegseth defends Anthropic's blacklisting over AI usage restrictions, citing national security risks amid the company's lawsuit.

AI Technology

Capgemini's Outcome IQ enhances the Ryder Cup experience with real-time analytics, capturing 5 million views and engaging fans across 160 countries.

AI Generative

Generative AI users, including those leveraging OpenAI's ChatGPT, risk copyright liability as courts explore the legal implications of AI-generated content.

AI Regulation

iFlytek's stock struggles amid regulatory pressures and a tech slowdown, raising investor caution as growth in AI faces geopolitical and compliance risks.

AI Business

Amazon's stock drops as focus shifts to AI, while Walmart's e-commerce sales soar 24%, highlighting a stark contrast in retail strategies.

© 2025 AIPressa · Part of Buzzora Media · All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site. Some images used on this website are generated with artificial intelligence and are illustrative in nature. They may not accurately represent the products, people, or events described in the articles.